Abstract: A device and method for monitoring electromyographic signals at a wearable health-data device that selectively monitors bioelectrical signals of a human body on a single limb. The device, such as a smart-watch or bracelet, has a body with a surface having at least two electrical contacts that are placed apart from each other and conductively held against the human body such that a bioelectrical electrical signal is passed between the two electrical contacts. There can be a computer platform contained within or on the device body that selectively monitors bioelectrical signals, isolates one or more electromyographic signals within the monitored bioelectrical signals, compiles respiratory effort data from the one or more electromyographic signals, and selectively outputs the respiratory effort data. An existing health-data device, with one body-facing contact, can also be modified with a fitting that allows dual contacts to be simultaneously held against the human body.

Abstract: The invention relates to compounds of formula (I), and related aspects.

Abstract: The invention relates to compounds of formula (I), and related aspects.

Abstract: The invention relates to compounds of formula (I), and related aspects.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between 0 ?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between 0 ?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between 0 ?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between 0 ?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between O?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between 0 ?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between Ops and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: Two biomarkers are provided for obstructive apnea. A first biomarker determines amplitude and timing of inspiratory efforts from a bioelectric signal. The respiratory rate is compared with a normal pre-detection rate, and the amplitude of the effort is compared with a normal amplitude. The obstructive apnea is likely present if a series of inspiratory efforts are above a normal amplitude and with increasing amplitude, but at a normal rate. A second biomarker determines heart rate and respiratory rate. A normal lower threshold for heartbeat interval is established, and if subthreshold events occur (short RR intervals), a commencement time for each sequence of subthreshold events is compared for a respiratory rate-normalized window. If the number of subthreshold events exceeds a minimum for the window, obstructive apnea is likely present.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between 0 ?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: Two biomarkers are provided for obstructive apnea. A first biomarker determines amplitude and timing of inspiratory efforts from a bioelectric signal. The respiratory rate is compared with a normal pre-detection rate, and the amplitude of the effort is compared with a normal amplitude. The obstructive apnea is likely present if a series of inspiratory efforts are above a normal amplitude and with increasing amplitude, but at a normal rate. A second biomarker determines heart rate and respiratory rate. A normal lower threshold for heartbeat interval is established, and if subthreshold events occur (short RR intervals), a commencement time for each sequence of subthreshold events is compared for a respiratory rate-normalized window. If the number of subthreshold events exceeds a minimum for the window, obstructive apnea is likely present.

Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between O?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.

Abstract: The present disclosure relates to a system for prevention of sudden death that includes a wearable seizure detection device; a base unit; and a computer, the computer configured to receive input from the seizure detection device and trigger the base unit to release oxygen under a condition effective to enrich an environmental oxygen level and prevent sudden death when the input indicates a seizure. Also disclosed is a portable system for preventing sudden death, where the system includes an oronasal mask; a compressed oxygen cartridge, wherein the compressed oxygen cartridge is coupled to the oronasal mask; and a fastener, wherein the fastener is coupled to the oronasal mask, wherein the system releases oxygen upon activation under a condition effective to enrich an environmental oxygen level and prevent sudden death. Further disclosed are methods of preventing sudden death comprising enriching an environmental oxygen level for a subject using the systems described.

Abstract: Associating a user service with a telephony identifier. The user service is accessible by a user of a telephony device via an application on the telephony device. The telephony device is operable in a radio telephony network (RTN) and is contactable via the telephony identifier when operating in the RTN. Network equipment: communicates, between the network equipment and the application on the telephony device, first data comprising a communicated token; receives, from the telephony device, second data comprising a received token, wherein the second data is received from the telephony device via an RTN-native service; receives, from a network node in the RTN, the telephony identifier in control signalling associated with the RTN-native service; and based at least on correlating the received token with the communicated token, associates the received telephony identifier with the user service.

Abstract: A foldable golf trolley comprising a chassis; at least one electrically powered rear drive wheel; a wheel support arm mounted to the front of the chassis supporting a front wheel; a stabilizer arm mounted to the rear of the chassis supporting a stabilizer wheel; a main support mounted to the chassis and a handle mounted to the main support; wherein the main support, the wheel support arm and the stabilizer arm are rotatably mounted to the chassis and movable between an operative configuration and a folded configuration; and gears connecting the stabilizer arm and main support, wherein rotation of the main support between the operative configuration and the folded configuration cause rotation of the stabilizer arm between the operative configuration and the folded configuration.

Abstract: Associating a user service with a telephony identifier. The user service is accessible by a user of a telephony device via an application on the telephony device. The telephony device is operable in a radio telephony network (RTN) and is contactable via the telephony identifier when operating in the RTN. Network equipment: communicates, between the network equipment and the application on the telephony device, first data comprising a communicated token; receives, from the telephony device, second data comprising a received token, wherein the second data is received from the telephony device via an RTN-native service; receives, from a network node in the RTN, the telephony identifier in control signalling associated with the RTN-native service; and based at least on correlating the received token with the communicated token, associates the received telephony identifier with the user service.